Prescription Drug Information: LymePak (Page 4 of 4)

PRINCIPAL DISPLAY PANEL — 100 mg Tablet Blister Pack

NDC 72336-596-86

LYMEPAK
(doxycycline hyclate tablets)

14 Tablets | 7 Day Supply

100mg*

R x Only

PRINCIPAL DISPLAY PANEL -- 100 mg Tablet Blister Pack
(click image for full-size original)

PRINCIPAL DISPLAY PANEL — 100 mg Tablet Blister Pack Carton

NDC 72336-596-87

LYMEPAK
(doxycycline hyclate tablets)

Contains 3 Cards Each Card with:
14 Tablets | 21 Day Supply

100mg*

R x Only

PRINCIPAL DISPLAY PANEL -- 100 mg Tablet Blister Pack Carton
(click image for full-size original)
LYMEPAK
doxycycline hyclate tablet, film coated
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:72336-596
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
DOXYCYCLINE HYCLATE (DOXYCYCLINE ANHYDROUS) DOXYCYCLINE ANHYDROUS 100 mg
Inactive Ingredients
Ingredient Name Strength
ANHYDROUS LACTOSE
SILICON DIOXIDE
D&C YELLOW NO. 10
FD&C BLUE NO. 1
FD&C YELLOW NO. 6
HYPROMELLOSE, UNSPECIFIED
MAGNESIUM STEARATE
METHYLCELLULOSE (400 MPA.S)
MICROCRYSTALLINE CELLULOSE
POLYETHYLENE GLYCOL, UNSPECIFIED
SODIUM STARCH GLYCOLATE TYPE A POTATO
STEARIC ACID
TITANIUM DIOXIDE
Product Characteristics
Color green Score no score
Shape ROUND Size 9mm
Flavor Imprint Code LP1
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:72336-596-87 3 BLISTER PACK in 1 CARTON contains a BLISTER PACK (72336-596-86)
1 NDC:72336-596-86 14 TABLET, FILM COATED in 1 BLISTER PACK This package is contained within the CARTON (72336-596-87)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA209844 09/10/2021
Labeler — LIFSA DRUGS LLC (081205160)
Establishment
Name Address ID/FEI Operations
Chartwell Pharmaceuticals LLC 962619982 analysis (72336-596), label (72336-596), manufacture (72336-596), pack (72336-596)

Revised: 09/2021 LIFSA DRUGS LLC

Page 4 of 4 1 2 3 4

RxDrugLabels.com provides trustworthy package insert and label information about marketed prescription drugs as submitted by manufacturers to the U.S. Food and Drug Administration. Package information is not reviewed or updated separately by RxDrugLabels.com. Every individual prescription drug label and package insert entry contains a unique identifier which can be used to secure further details directly from the U.S. National Institutes of Health and/or the FDA.

As a leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. RxDrugLabels.com provides the full prescription-only subset of the FDA's repository. Medication information provided here is not intended as a substitute for direct consultation with a qualified health professional.

Terms of Use | Copyright © 2021. All Rights Reserved.